Regulators of ovarian functions

Regulators of Ovarian Functions

Volumn , Issue , 2011, Pages 1-194

  Sirotkin, Alexander V ^a  

^a Research Inst of Animal Protection   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895247008     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (486)

1. Sirotkin AV, Makarevich AV, Grossmann R, Kotwica J, Schaeffer H-J, Marnet P-G, Kwon H, Sanislo P, Florkovicova I, Petrak J, Rafal J, Pivko J, Hetenyi L. Regulators of ovarian function. In: Regulation and Evaluation of Ovarian Function and Embryogenesis in Normal and Transgenic Animals in vitro and in vivo"(M.R. Luck ed.). Research Institute of Animal Production, Nitra, Slovakia, 2003, pp. 9-25.
2. Sirotkin AV. Control of reproductive processes by growth hormone: extra- and intracellular mechanisms. Vet J. 2005 170:307-317.
3. Sirotkin AV, Luck M. The ovarian cycle, oogenesis and their regulation. In: Animal Biotechnology (J. Laurincik ed.), Constantine the Philosopher University in Nitra, Prírodovedec, Nitra, SR, 2008, pp. 10-28.
4. Sirotkin AV., Makarevich AV, Grossmann R. Protein kinases and ovarian functions. J Cell Physiol. 2010 226:37-45.
5. Sirotkin AV. Protein kinases: signaling molecules controlling ovarian functions. The Int J Biochemistry & Cell Biol 2010a 42:1927-1930.
6. Sirotkin AV. RNA interference and ovarian functions. J Cell Physiol. 2010b 225:345-363.
7. Sirotkin AV. Transcription factors and ovarian functions J Cell Physiol. 2010c 225:20-26.
8. Adams GP, Jaiswal R, Singh J, Malhi P. Progress in understanding ovarian follicular dynamics in cattle. Theriogenology. 2008 69:72-80.
9. Aerts JM, Bols PE. Ovarian follicular dynamics. A review with emphasis on the bovine species. Part II: Antral development, exogenous influence and future prospects. Reprod Domest Anim. 2008b 45:180-187.
10. Aerts JM, Bols PE. Ovarian follicular dynamics: A review with emphasis on the bovine species. Part I: Folliculogenesis and pre-antral follicle development. Reprod Domest Anim. 2008a 45:171-179.
11. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006 12:685-718.
12. Craig J, Resaca M, Wang H, Resaca S, Thompson W, Zhu C, Kostunica F, Tsang BK. Gonadotropin and intra-ovarian signals regulating follicle development and atresia: the delicate balance between life and death. Front Biosci. 2007 12:3628-3639.
13. Feng WG, Sui HS, Han ZB, Chang ZL, Zhou P, Liu DJ, Bao S, Tan JH. Effects of follicular atresia and size on the developmental competence of bovine oocytes: a study using the well-in-drop culture system. Theriogenology. 2007 67:1339-1350.
14. Fortune JE. The early stages of follicular development: activation of primordial follicles and growth of preantral follicles. Anim Reprod Sci. 2003 78:135-163
15. Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008 14:367-378.
16. Gadsby J, Rose L, Sriperumbudur R, Ge Z. The role of intra-luteal factors in the control of the porcine corpus luteum. Soc Reprod Fertil 2006 Suppl. 62:69-83.
17. Gougeon A. Dynamics of human follicular growth: morphologic, dynamic, and functional aspects. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 25-43.
18. Hall JE. Neuroendocrine changes with reproductive aging in women. Semin Reprod Med. 2007 25:344-351.
19. Hrometz SL, Gates VA. Review of available infertility treatments. Drugs Today (Barc) 2009 45:275-291.
20. Hunter, Robinson RS, Mann GE, Webb R. Endocrine and paracrine control of follicular development and ovulation rate in farm species. Anim Reprod Sci. 2004 82-83:461-477.
21. Hutt KJ, Albertini DF An oocentric view of folliculogenesis and embryogenesis. Reprod Biomed Online. 2007 14:758-764.
22. Irving-Rodgers HF, Rodgers RJ. Extracellular matrix of the developing ovarian follicle. Semin Reprod Med. 2006 24:195-203.
23. Lonergan P. State-of-the-art embryo technologies in cattle. Soc Reprod Fertil 2007 Suppl.64:315-325
24. McLaughlin EA, McIver SC. Awakening the oocyte: controlling primordial follicle development. Reproduction. 2009 137:1-11.
25. Meidan R, Levy N, Kisliouk T, Podlovny L, Rusiansky M, Klipper E. The yin and yang of corpus luteum-derived endothelial cells: balancing life and death. Domest Anim Endocrinol. 2005 29:318-328.
26. Mermillod P, Dalbiès-Tran R, Uzbekova S, Thélie A, Traverso JM, Perreau C, Papillier P, Monget P. Factors affecting oocyte quality: who is driving the follicle? Reprod Domest Anim. 2008 43 Suppl 2:393-400.
27. Mihm M, Evans AC. Mechanisms for dominant follicle selection in monovulatory species: a comparison of morphological, endocrine and intraovarian events in cows, mares and women. Reprod Domest Anim. 2008 43 Suppl 2:48-56.
28. Miyano T, Manabe N. Oocyte growth and acquisition of meiotic competence. Soc Reprod Fertil Suppl. 2007 63:531-538.
29. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 2000 80: 1-29.
30. Niswender GD. Molecular control of luteal secretion of progesterone. Reproduction. 2002 123:333-339
31. Oktem O, Oktay K. The ovary: anatomy and function throughout human life. Ann N Y Acad Sci. 2008 1127:1-9.
32. Peter AT, Levine H, Drost M, Bergfelt DR. Compilation of classical and contemporary terminology used to describe morphological aspects of ovarian dynamics in cattle. Theriogenology. 2009 71:1343-1357.
33. Roudebush WE, Kivens WJ, Mattke JM. Biomarkers of ovarian reserve. Biomark Insights. 2008 3:259-268.
34. Rueda BR, Hendry IR, Hendry WJ III, Fong HW, Stormashak F, Slaydenlayden OD, Davis JS. Decreased progesterone level and progesterone receptors antagonists promote apoptotic cell death in bovine luteal cells. Biol Reprod 2000 62:269-276.
35. Skarzynski DJ, Ferreira-Dias G, Okuda K. Regulation of luteal function and corpus luteum regression in cows: hormonal control, immune mechanisms and intercellular communication. Reprod Domest Anim. 2008 43 Suppl 2:57-65.
36. Skinner MK. Regulation of primordial follicle assembly and development. Hum Reprod Update. 2005 11:461-471.
37. Stouffer RL. The function and regulation of cell populations comprising the corpus luteum during the ovarian cycle. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 169-184.
38. Tingen C, Kim A, Woodruff TK . The primordial pool of follicles and nest breakdown in mammalian ovaries. Mol Hum Reprod. 2009 15:795-803.
39. Webb R, Campbell BK. Development of the dominant follicle: mechanisms of selection and maintenance of oocyte quality. Soc Reprod Fertil. Suppl. 2007 64:141-163.
40. Aerts JM, Bols PE. Ovarian follicular dynamics: a review with emphasis on the bovine species. Part I: Folliculogenesis and pre-antral follicle development. Reprod Domest Anim. 2008 45:171-179.
41. Brevini TA, Cillo F, Antonini S, Gandolfi F. Cytoplasmic remodelling and the acquisition of developmental competence in pig oocytes. Anim Reprod Sci. 2007 98:23-38.
42. Dekel N. Cellular, biochemical and molecular mechanisms regulating oocyte maturation. Mol Cell Endocrinol. 2005 234:19-25.
43. Eppig JI, Vivelros MM, Martin-Bivens C, De La Fuente R. Oocyte maturation and ovulation. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 113-129.
44. Feng WG, Sui HS, Han ZB, Chang ZL, Zhou P, Liu DJ, Bao S, Tan JH. Effects of follicular atresia and size on the developmental competence of bovine oocytes: a study using the well-in-drop culture system. Theriogenology. 2007 67:1339-1350.
45. Ferreira EM, Vireque AA, Adona PR, Meirelles FV, Ferriani RA, Navarro PA Cytoplasmic maturation of bovine oocytes: structural and biochemical modifications and acquisition of developmental competence. Theriogenology. 2009 71:836-848.
46. Grøndahl C.Oocyte maturation. Basic and clinical aspects of in vitro maturation (IVM) with special emphasis of the role of FF-MAS. Dan Med Bull. 2008 55:1-16.
47. Hashimoto S. Application of in vitro maturation to assisted reproductive technology. J Reprod Dev. 2009 55:1-10.
48. Hrometz SL, Gates VA. Review of available infertility treatments. Drugs Today (Barc). 2009 45:275-291.
49. Hutt KJ, Albertini DF. An oocentric view of folliculogenesis and embryogenesis. Reprod Biomed Online. 2007 14:758-764.
50. Kimura N, Hoshino Y, Totsukawa K, Sato E. Cellular and molecular events during oocyte maturation in mammals: molecules of cumulus-oocyte complex matrix and signalling pathways regulating meiotic progression. Soc Reprod Fertil Suppl. 2007 63:327-342.
51. Lonergan P. State-of-the-art embryo technologies in cattle. Soc Reprod Fertil 2007 Suppl.64:315-325
52. McLaughlin EA, McIver SC. Awakening the oocyte: controlling primordial follicle development. Reproduction. 2009 137:1-11.
53. Mermillod P, Dalbiès-Tran R, Uzbekova S, Thélie A, Traverso JM, Perreau C, Papillier P, Monget P. Factors affecting oocyte quality: who is driving the follicle? Reprod Domest Anim. 2008 43 Suppl 2:393-400.
54. Miyano T, Manabe N. Oocyte growth and acquisition of meiotic competence. Soc Reprod Fertil Suppl. 2007 63:531-538.
55. van den Hurk R, Zhao J. Formation of mammalian oocytes and their growth, differentiation and maturation within ovarian follicles. Theriogenology. 2005 63:1717-1751.
56. Webb R, Campbell BK. Development of the dominant follicle: mechanisms of selection and maintenance of oocyte quality. Soc Reprod Fertil Suppl. 2007 64:141-163.
57. Abayasekara DR, Michael AE, Webley GE, Flint AP. Mode of action of prostaglandin F2 alpha in human luteinized granulosa cells: role of protein kinase C. Mol Cell Endocrinol. 1993 97:81-91.
58. Adriaens I, Jacquet P, Cortvrindt R, Janssen K, Smitz J. Melatonin has dose-dependent effects on folliculogenesis, oocyte maturation capacity and steroidogenesis. Toxicology. 2006 228:333-343.
59. Ben-Ami I, Freimann S, Armon L, Dantes A, Ron-El R, Amsterdam A. Novel function of ovarian growth factors: combined studies by DNA microarray, biochemical and physiological approaches. Mol Hum Reprod. 2006 12:413-419.
60. Benco A, Sirotkin AV, Vasícek D, Pavlová S, Zemanová J, Kotwica J, Darlak K, Valenzuela F. Involvement of the transcription factor STAT1 in the regulation of porcine ovarian granulosa cell functions treated and not treated with ghrelin. Reproduction. 2009 138:553-560.
61. Berisha B, Schams D. Ovarian function in ruminants. Domest Anim Endocrinol. 2005 29:305-317
62. Berlinguer F, Leoni GG, Succu S, Spezzigu A, Madeddu M, Satta V, Bebbere D, Contreras-Solis I, Gonzalez-Bulnes A, Naitana S. Exogenous melatonin positively influences follicular dynamics, ovocyte developmental competence and blastocyst output in a goat model. J Pineal Res. 2009 46:383-391.
63. Bornstein SR, Rutkowski H, Vrezas I. Cytokines and steroidogenesis. Mol Cell Endocrinol. 2004 215:135-141.
64. Brännström M. Potential role of cytokines in ovarian physiology: the case for interleukin-1. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 261-271.
65. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006 12:685-718.
66. Chapman S.C., Kenny HA, Woodruff TK. Activin, inhibin and follistatin in ovarian physiology. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 273-287.
67. Conti M, Hsieh M, Park JY, Su YQ. Role of the epidermal growth factor network in ovarian follicles. Mol Endocrinol. 2006 20:715-723.
68. Craig J, Zhu H, Dyce PW, Petrik J, Li J. Leptin enhances oocyte nuclear and cytoplasmic maturation via the mitogen-activated protein kinase pathway. Endocrinology. 2004 145:5355-5363.
69. Deng J, Carbajal L, Evaul K, Rasar M, Jamnongjit M, Hammes SR. Nongenomic steroid-triggered oocyte maturation: of mice and frogs. Steroids. 2009 74:595-601.
70. Denkova R, Bourneva V, Staneva-Dobrovski L, Zvetkova E, Baleva K, Yaneva E, Nikolov B, Ivanov I, Simeonov K, Timeva T, Yankov M. In vitro effects of inhibin on apoptosis and apoptosis related proteins in human ovarian granulosa cells. Endocr Regul. 2004 38:51-55.
71. Dhillo WS, Murphy KG, Bloom S. Endocrinology: the next 60 years. J Endocrinol. 2006 190:7-10.
72. DiLuigi AJ, Nulsen JC. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function. Curr Opin Obstet Gynecol. 2007 19:258-265.
73. Dou J, Wang Y, Wang J, Zhao F, Li Y, Cao M, Hu W, Hu K, He XF, Chu L, Jiang C, Gu N. Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model. Immunobiology. 2009 214:483-492.
74. Drummond AE. The role of steroids in follicular growth. Reprod Biol Endocrinol. 2006 4:16-27.
75. Dubé F, Amireault P. Local serotonergic signaling in mammalian follicles, oocytes and early embryos. Life Sci. 2007 81:1627-1637.
76. Finocchiaro LM, Glikin GC. Intracellular melatonin distribution in cultured cell lines. J Pineal Res. 1998 24:22-34.
77. Fru KN, Cherian-Shaw M, Puttabyatappa M, VandeVoort CA, Chaffin CL. Regulation of granulosa cell proliferation and EGF-like ligands during the periovulatory interval in monkeys. Hum Reprod. 2007 22:1247-1252.
78. Furuhashi M, Miyabe Y, Oda H. A case of thrombopoietin-producing ovarian carcinoma confirmed by immunohistochemistry. Gynecol Oncol. 1999 74:278-81.
79. Garcia MC, Lopez M, Alvarez CV, Casanueva F, Tena-Sempere M, Dieguez C. Role of ghrelin in reproduction. Reproduction. 2007 133:531-540.
80. Geva E, Jaffe RB. Ovarian angiogenesis. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 305-317..
81. Ghuman SP, Singh J, Honparkhe M, Dadarwal D, Dhaliwal GS, Jain AK. Induction of ovulation of ovulatory size non-ovulatory follicles and initiation of ovarian cyclicity in summer anoestrous Buffalo heifers (Bubalus bubalis) using melatonin implants. Reprod Domest Anim. 2008 Dec 15. [Epub ahead of print, PMID: 19090824].
82. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001 81:629-683.
83. Giudice LC. Insulin-like growth factor family in Graafian follicle development and function. J Soc Gynecol Investig. 2001 8(1 Suppl):S26-S29.
84. Gómez-Raposo C, Mendiola M, Barriuso J, Casado E, Hardisson D, Redondo A. Angiogenesis and ovarian cancer. Clin Transl Oncol. 2009 11:564-571.
85. Gotlieb WH, Bruchim I, Gu J, Shi Y, Camirand A, Blouin MJ, Zhao Y, Pollak MN. Insulin-like growth factor receptor I targeting in epithelial ovarian cancer. Gynecol Oncol. 2006 100:389-396.
86. Gregoraszczuk EL, Ptak A. In vitro effect of leptin on growth hormone (GH)- and insulin-like growth factor-I (IGF-I)-stimulated progesterone secretion and apoptosis in developing and mature corpora lutea of pig ovaries J Reprod Dev. 2005 51:727-733.
87. Hemadi M, Abolhassani F, Akbari M, Sobhani A, Pasbakhsh P, Ahrlund-Richter L, Modaresi MH, Salehnia M. Melatonin promotes the cumulus-oocyte complexes quality of vitrified-thawed murine ovaries; with increased mean number of follicles survival and ovary size following heterotopic transplantation. Eur J Pharmacol. 2009 618:84-90.
88. Hernandez ER, Resnick CE, Svoboda ME, Van Wyk JJ, Payne DW, Adashi EY. Somatomedin-C/insulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells. Endocrinology. 1988 122:1603-1612.
89. Hunter MG, Robinson RS, Mann GE, Webb R. Endocrine and paracrine control of follicular development and ovulation rate in farm species. Anim Reprod Sci. 2004 82-83:461-477.
90. Hunzicker-Dunn M, Maizels ET. FSH signaling pathways in immature granulosa cells that regulate target gene expression: Branching out from protein kinase A. Cell Signal. 2006 18:1351-1359.
91. Hsieh M, Zamah AM, Conti M. Epidermal growth factor-like growth factors in the follicular fluid: role in oocyte development and maturation. Semin Reprod Med. 2009 27:52-61.
92. Huhtaniemi I/ Functional consequences of mutations and polymorphism in gonadotropin and gonadotropin receptor genes. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 55-78.
93. Jiang JY, Cheung CK, Wang Y, Tsang BK. Regulation of cell death and cell survival gene expression during ovarian follicular development and atresia. Front Biosci. 2003 8:222-237.
94. Katska-Ksiazkiewicz L, Lechniak-Cieslak D, Korwin-Kossakowska A, Alm H, Rynska B, Warzych E, Sosnowski J, Sender G. Genetical and biotechnological methods of utilization of female reproductive potential in mammals. Reprod Biol. 2006 6 Suppl 1:21-36.
95. Kaszubska W, Zhang H, Patterson RL, Suhar TS, Uchic ME, Dickinson RW, Schaefer VG, Haasch D, Janis RS, DeVries PJ, Okasinski GF, Meuth JL. Expression, purification, and characterization of human recombinant thrombopoietin in Chinese hamster ovary cells. Protein Exp Purif. 2000 18:213-220.
96. Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006 354: 2034-2045.
97. Kheradmand A, Alirezaei M, Birjandi M. Ghrelin promotes antioxidant enzyme activity and reduces lipid peroxidation in the rat ovary. Regul Pept. 2010 162:84-89.
98. Kim J, Bagchi IC, Bagchi MK. Signaling by hypoxia-inducible factors is critical for ovulation in mice. Endocrinology. 2009 150:3392-3400.
99. Kim K, Visintin I, Alvero AB, Mor G. Development and validation of a protein-based signature for the detection of ovarian cancer. Clin Lab Med. 2009 29:47-55.
100. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8:21-34.
101. Kolibianakis EM, Papanikolaou EG, Fatemi HM, Devroey P. Estrogen and folliculogenesis: is one necessary for the other? Curr Opin Obstet Gynecol. 2005 17:249-253.
102. Kooistra HS, Okkens AC. Secretion of prolactin and grwth hormone in relation to ovarian activity in dog. Reprod Dom Anim. 2001 36:115-119.
103. Koppan M, Bodis J, Verzar Z, Tinneberg HR, Torok A. Serotonin may alter the pattern of gonadotropin-induced progesterone release of human granulosa cells in superfusion system. Endocrine. 2004 24:155-159.
104. Korwin-Kossakowska A, Wyszynska-Koko J, Sender G, Gajewska A, Pierzchala M, Kamyczek M, Kochman K. Effect of the polymorphism in 5' UTR region of pig prolactin gene on prolactin gene expression and reproduction performance in tle female pig. Neuro Endocrinol Lett. 2009 30:221-226.
105. Kucharski J, Jana B. Immuno-endocrine mechanisms connected with the creation of corpora lutea persistent in animal ovaries. Pol J Vet Sci. 2005 8:255-259.
106. Kumar TR. Functional analysis of LHbeta knockout mice. Mol Cell Endocrinol. 2007 269:81-84.
107. Kun Z, Shaohua W, Yufang M, Yankun L, Hengxi W, Xiuzhu S, Yonghui Z, Yan L, Yunping D, Lei Z, Ning L. Effects of leptin supplementation in in vitro maturation medium on meiotic maturation of oocytes and preimplantation development of parthenogenetic and cloned embryos in pigs. Anim Reprod Sci. 2007 101:85-96.
108. Lafky JM, Wilken JA, Baron AT, Maihle NJ. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta. 2008 1785:232-265.
109. Lenie S, Smitz J. Functional AR signaling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis. Biol Reprod. 2009 80:685-695.
110. Leung PCK. and Cheng CK. Gn-RH as an autocrine regulator in the human ovary. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 289-304.
111. Li Q, Rajanahally S, Edson MA, Matzuk MM. Stable expression and characterization of N-terminal tagged recombinant human bone morphogenetic protein 15. Mol Hum Reprod. 2009 15:779-788.
112. Li YF, Hu W, Fu SQ, Li JD, Liu JH, Kavanagh JJ. Aromatase inhibitors in ovarian cancer: is there a role? Int J Gynecol Cancer. 2008 18:600-614.
113. Lucy MC. Functional differences in the growth hormone and insulin-like growth factor axis in cattle and pigs: implications for post-partum nutrition and reproduction. Reprod Domest Anim. 2008 43 Suppl 2:31-39.
114. Manabe N, Matsuda-Minehata F, Goto Y, Maeda A, Cheng Y, Nakagawa S, Inoue N, Wongpanit K, Jin H, Gonda H, Li J. Role of cell death ligand and receptor system on regulation of follicular atresia in pig ovaries. Reprod Domest Anim. 2008 43 Suppl 2:268-272.
115. Markman M. The promise and perils of "targeted therapy? of advanced ovarian cancer. Oncology 2008 74:1-6.
116. McNeilly AS. Lactation and fertility. J Mammary Gland Biol Neoplasia. 1997 2:291-298.
117. Mészárosová M, Sirotkin AV, Grossmann R, Darlak K, Valenzuela F. The effect of obestatin on porcine ovarian granulosa cells. Animal Reproduction Sci. 2008 108:196-207.
118. Mihm M, Evans AC. Mechanisms for dominant follicle selection in monovulatory species: a comparison of morphological, endocrine and intraovarian events in cows, mares and women. Reprod Domest Anim. 2008 43 Suppl 2:48-56.
119. Mircea CN, Lujan ME, Pierson RA. Metabolic fuel and clinical implications for female reproduction. J Obstet Gynaecol Can. 2007 29:887-902.
120. Motola S, Cao X, Ashkenazi H, Popliker M, Tsafriri A. GnRH actions on rat preovulatory follicles are mediated by paracrine EGF-like factors. Mol Reprod Dev. 2006 73:1271-1276.
121. Munoz-Gutierrez M, Findlay PA, Adam CL, Wax G, Campbell BK, Kendall NR, Khalid M, Forsberg M, Scaramuzzi RJ. The ovarian expression of mRNAs for aromatase, IGF-I receptor, IGF-binding protein-2, -4 and -5, leptin and leptin receptor in cycling ewes after three days of leptin infusion. Reproduction 2005 130:869-881.
122. Natesampillai S, Veldhuis JD. Action of insulin and insulin-like growth factor -1 on sterol-metabolizing gene expression in ovarian cells. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 249-259.
123. Nelson SM, Yates RW Lyall H, Jamieson M, Traynor I, Gaudoin M, Mitchell P, Ambrose P, Fleming R. Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Human Reproduction 2009 1:1-9.
124. Nguyen NT, Lin DP, Yen SY, Tseng JK, Chuang JF, Chen BY, Lin TA, Chang HH, Ju JC. Sonic hedgehog promotes porcine oocyte maturation and early embryo development. Reprod Fertil Dev. 2009 21:805-815.
125. Nilsson E, Rogers N, Skinner MK. Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction. 2007 134:209-221.
126. Niswender GD, Davis TL, Griffith RJ, Bogan RL, Monser K, Bott RC, Bruemmer JE, Nett TM. Judge, jury and executioner: the auto-regulation of luteal function. Soc Reprod Fertil Suppl. 2007 64:191-206.
127. Norris DO. Vertebrate Endocrinology. Fourth edition. Elsevier-Academic Press, Amsterdam et al., 2006, 560 pp.
128. Palermo R. Differential actions of FSH and LH during folliculogenesis. Repris Biomed Online. 2007 15:326-337.
129. Pangas SA. Growth factors and ovarian development. Semin Reprod Med 2007 25:225-234.
130. Panigone S, Hsieh M, Fu M, Persani L, Conti M. Luteinizing hormone signaling in preovulatory follicles involves early activation of the epidermal growth factor receptor pathway. Mol Endocrinol. 2008 22:924-936.
131. Paragh G, Kumar SM, Rakosy Z, Choi SC, Xu X, Acs G. RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells. Am J Pathol. 2009 174:1504-1514.
132. Patiño R, Yoshizaki G, Thomas P, Kagawa H. Gonadotropic control of ovarian follicle maturation: the two-stage concept and its mechanisms. Comp Biochem Physiol B Biochem Mol Biol. 2001 129:427-439.
133. Peluso JJ. Non-genomic actions of progesterone in the normal and neoplastic mammalian ovary. Semin Reprod Med. 2007 25:198-207.
134. Peluso JJ, Liu X, Gawkowska A, Johnston-MacAnanny E. Progesterone activates a progesterone receptor membrane component 1-dependent mechanism that promotes human granulosa/luteal cell survival but not progesterone secretion. J Clin Endocrinol Metab. 2009 94:2644-2649.
135. Pinelli G, Tagliabue A. Nutrition and fertility. Minerva Gastroenterol Dietol. 2007 53:375-382.
136. Pope WF, Cárdenas H. Androgens in female pig reproduction: actions mediated by the androgen receptor. Soc Reprod Fertil Suppl. 2006 62:55-67.
137. Quirk SM, Cowan RG, Harman RM, Hu CL, Porter DA. Ovarian follicular growth and atresia: the relationship between cell proliferation and survival. J Anim Sci. 2004 82 E-Suppl:E40-E52.
138. Ramakrishnappa N, Rajamahendran R, Lin YM, Leung PC. GnRH in non-hypothalamic reproductive tissues. Anim Reprod Sci. 2005 88:95-113.
139. Rebar RW. Premature ovarian failure. Obstet Gynecol. 2009 113:1355-1363.
140. Reisinger K, Baal N, McKinnon T, Münstedt K, Zygmunt M. The gonadotropins: tissue-specific angiogenic factors? Mol Cell Endocrinol. 2007 269:65-80.
141. Rose SL. Notch signaling pathway in ovarian cancer. Int J Gynecol Cancer. 2009 19:564-566.
142. Ryll T, Dutina G, Reyes A, Gunson J, Krummen L, Etcheverry T. Performance of small-scale CHO perfusion cultures using an acoustic cell filtration device for cell retention: characterization of separation efficiency and impact of perfusion on product quality. Biotechnol Bioeng. 2000 69:440-449.
143. Salmassi A, Mettler L, Jonat W, Buck S, Koch K, Schmutzler AG. Circulating level of macrophage colony-stimulating factor can be predictive for human in vitro fertilization outcome. Fertil Steril. 2010 116-123.
144. Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev. 2009 30:343-375.
145. Schoyer KD, Liu HC, Witkin S, Rosenwaks Z, Spandorfer SD Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome. Fertil Steril. 2007 88:139-144.
146. Silva JR, Tharasanit T, Taverne MA, van der Weijden GC, Santos RR, Figueiredo JR, van den Hurk R. The activin-follistatin system and in vitro early follicle development in goats. J Endocrinol. 2006 189:113-125.
147. Simpson JL. Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Ann N Y Acad Sci. 2008 1135:146-154.
148. Sirois J, Boerboom D, Sayasith K. Prostaglandin biosynthesis and action in the ovary. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 233-247.
149. Sirotkin AV, Nitray J, Skokanova A, Politov VP, Jurcovicova J, Marinchenko GV. Release of a prolactin-like substance by bovine granulosa cells in vitro: effects of ovarian steroids. Ann Endocrinol (Paris). 1994 55:279-282.
150. Sirotkin AV, Makarevich AV, Kwon HB, Kotwica J, Bulla J, Hetényi L. Do GH, IGF-I and oxytocin interact by regulating the secretory activity of porcine ovarian cells? J Endocrinol. 2001 171:475-480
151. Sirotkin AV, Makarevich AV, Grossmann R, Kotwica J, Schaeffer H-J, Marnet P-G, Kwon H, Sanislo P, Florkovicova I, Petrak J, Rafal J, Pivko J, Hetenyi L. Regulators of ovarian function. In: "Regulation and Evaluation of Ovarian Function and Embryogenesis in Normal and Transgenic Animals in vitro and in vivo" (M.R. Luck ed.). Research Institute of Animal Production, Nitra, Slovakia, 2003, pp. 9-25.
152. Sirotkin AV, Sanislo P, Schaeffer HJ, Florkovicová I, Kotwica J, Bulla J, Hetényi L. Thrombopoietin regulates proliferation, apoptosis, secretory activity and intracellular messengers in porcine ovarian follicular cells: involvement of protein kinase A. J Endocrinol. 2004 183:595-604.
153. Sirotkin AV. Control of reproductive processes by growth hormone: extra- and intracellular mechanisms. Vet J. 2005 170:307-317.
154. Sirotkin AV, Mlyncek M, Kotwica J, Makarevich AV, Florkovicova I, Hetenyi L. Leptin directly controls secretory activity of human ovarian granulosa cells: possible inter-relationship with the IGF/IGFBP system. Horm Res 2005 64:198-202.
155. Sirotkin AV, Grossmann R, Maria-Peon MT, Roa J, Tena-Sempere M, Klein S. Novel expression and functional role of ghrelin in chicken ovary. Mol. Cell. Endocrinol. 2006 257-258:15-25.
156. Sirotkin AV, Grossmann R. Leptin directly controls proliferation, apoptosis and secretory activity of cultured chicken ovarian cells. Comp Biochem Physiol A Mol Integr Physiol 2007a 148:422-429.
157. Sirotkin AV, Grossmann R. The role of ghrelin and some intracellular mechanisms in controlling the secretory activity of chicken ovarian cells. Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. 2007b 147:239-246
158. Sirotkin AV, Benco A, Tandlmajerova A, Vasícek D, Kotwica J, Darlak K, Valenzuela F. Transcription factor p53 can regulate proliferation, apoptosis and secretory activity of luteinizing porcine ovarian granulosa cell cultured with and without ghrelin and FSH. Reproduction. 2008a 136:611-618.
159. Sirotkin AV, Mlyncek M, Makarevich AV, Florkovicova I, Hetenyi L. Leptin affects proliferation-, apoptosis- and protein kinase A-related peptides in human ovarian granulosa cells. Physiol Res 2008b 57:437-442.
160. Sirotkin AV, Rafay J, Kotwica J. Leptin controls rabbit ovarian function in vivo and in vitro: possible interrelationships with ghrelin. Theriogenology 2009b 72:765-772.
161. Sirotkin AV, Rafay J, Kotwica J, Darlak K, Valenzuela F. Role of ghrelin in regulating rabbit ovarian function and the response to LH and IGF-I. Domestic Animal Endocrinol. 2009c 36:162-172.
162. Sirotkin AV, Meszarošová M. Comparison of effects of leptin and ghrelin on porcine ovarian granulosa cells. Domestic Animal Endocrinol 2010 39:1-9.
163. Solár P, Koval J, Mikes J, Kleban J, Solárová Z, Lazúr J, Hodorová I, Fedorocko P, Sytkowski AJ. Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovaria cancer cells. Mol Cancer Ther. 2008 7:2263-2271.
164. Sondheimer SJ. Oral contraceptives: mechanism of action, dosing, safety, and efficacy. Cutis. 2008 81(1 Suppl):19-22.
165. Spicer LJ, Sudo S, Aad PY, Wang LS, Chun SY, Ben-Shlomo I, Klein C, Hsueh AJ. The hedgehog-patched signaling pathway and function in the mammalian ovary: a novel role for hedgehog proteins in stimulating proliferation and steroidogenesis of theca cells. Reproduction. 2009 138:329-339.
166. Stouffer RL, Xu F, Duffy DM. Molecular control of ovulation and luteinization in the primate follicle. Front Biosci. 2007 12:297-307.
167. Suzumori N, Pangas SA, Rajkovic A. Candidate genes for premature ovarian failure. Curr Med Chem. 2007 14:353-357.
168. Tai CJ, Kang SK, Choi KC, Tzeng CR, Leung PC. Role of mitogen-activated protein kinase in prostaglandin f(2alpha) action in human granulosa-luteal cells. J Clin Endocrinol Metab. 2001 86:375-380.
169. Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N, Reiter RJ. Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril. 2009 92:328-343.
170. Thomas FH, Armstrong DG, Telfer EE. Activin promotes oocyte development in ovine preantral follicles in vitro. Reprod Biol Endocrinol. 2003 1:76.
171. Toy EP, Azodi M, Folk NL, Zito CM, Zeiss CJ, Chambers SK. Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor. Neoplasia. 2009 11:136-144.
172. Tropea A, Tiberi F, Minici F, Orlando M, Gangale MF, Romani F, Miceli F, Catino S, Mancuso S, Sanguinetti M, Lanzone A, Apa R. (2007)Ghrelin affects the release of luteolytic and luteotropic factors in human luteal cells. J Clin Endocrinol Metab. 92:3239-3245.
173. Tsai EM, Chan TF, Chang Y, Chiang PH, Chuang CY, Long CY, Chai CY, Lee JN. Leptin suppresses human chorionic gonadotropin-induced cyclooxygenase-2 expression and prostaglandin production in cultured human granulose luteal cells. J Soc Gynecol Investig 2006 13:551-557.
174. Tsigkou A, Luisi S, Reis FM, Petraglia F. Inhibins as diagnostic markers in human reproduction. Adv Clin Chem. 2008 45:1-29.
175. Väänänen JE, Tong BL, Väänänen CM, Chan IH, Yuen BH, Leung PC. Interaction of prostaglandin F2alpha and gonadotropin-releasing hormone on progesterone and estradiol production in human granulosa-luteal cells. Biol Reprod. 1997 57:1346-1353.
176. van der Lely AJ, Tschop M, Heiman ML, Ghigo E., Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004 25, 426-457.
177. Vegetti W, Alagna F. FSH and folliculogenesis: from physiology to ovarian stimulation. Reprod Biomed Online. 2006 12:684-94.
178. Velazquez MA, Zaraza J, Oropeza A, Webb R, Niemann H. The role of IGF1 in the in vivo production of bovine embryos from superovulated donors. Reproduction. 2009 137:161-180.
179. Viani I, Vottero A, Tassi F, Cremonini G, Sartori C, Bernasconi S, Ferrari B,Ghizzoni L. Ghrelin inhibits steroid biosynthesis by cultured granulosa-lutein cells. J Clin Endocrinol Metab. 2008 93:1476-1481.
180. Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction. 2006 131:1-9.
181. Vitale AM, Gonzalez OM, Parborell F, Irusta G, Campo S, Tesone M. Inhibin a increases apoptosis in early ovarian antral follicles of diethylstilbestrol-treated rats. Biol Reprod. 2002 67:1989-1995.
182. Walters KA, Allan CM, Handelsman DJ. Androgen actions and the ovary. Biol Reprod. 2008 78:380-389.
183. Wang C, Roy SK. Expression of bone morphogenetic protein receptor (BMPR)during perinatal ovary development and primordial follicle formation in tle hamster: possible regulation by FSH. Endocrinology. 2009 150:1886-1896.
184. Webb R, Campbell BK. Development of the dominant follicle: mechanisms of selection and maintenance of oocyte quality. Soc Reprod Fertil Suppl. 2007 64:141-163.
185. Weems CW, Weems YS, Randel RD. Prostaglandins and reproduction in female farm animals. Vet J. 2006 171:206-228
186. .Wunsch A, Sonntag B, Simoni M. Polymorphism of the FSH receptor and ovaria response to FSH. Ann Endocrinol (Paris). 2007 68:160-166.
187. Xia Y, Schneyer AL. The biology of activin: recent advances in structure, regulation and function. J Endocrinol. 2009 202:1-12.
188. Yao N, Lu CL, Zhao JJ, Xia HF, Sun DG, Shi XQ, Wang C, Li D, Cui Y, Ma X. A network of miRNAs expressed in the ovary are regulated by FSH. Front Biosci. 2009 14:3239-3245.
189. Zachow R, Uzumcu M. The hepatocyte growth factor system as a regulator of female and male gonadal function. J Endocrinol. 2007 195:359-371.
190. Zerani M, Boiti C, Zampini D, Brecchia G, Dall'Aglio C, Ceccarelli P, Gobbetti A. Ob receptor in rabbit ovary and leptin in vitro regulation of corpora lutea. J Endocrinol. 2004 183:279-288.
191. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science. 2005 310:996-999.
192. Zieba DA, Amstalden M, Williams GL. Regulatory roles of leptin in reproduction and metabolism: a comparative review. Domest Anim Endocrinol. 2005 29:166-185.
193. Ziecik AJ, Blitek A, Kaczmarek MM, Waclawik A, Bogacki M. Inhibition of luteolysis and embryo-uterine interactions during the peri-implantation period in pigs. Soc Reprod Fertil Suppl. 2006 62:147-61.
194. Amsterdam A, Keren-Tal I, Aharoni D, Dantes A, Land-Bracha A, Rimon E, Sasson R, Hirsh L. Steroidogenesis and apoptosis in the mammalian ovary. Steroids. 2003 68:861-867.
195. Besant PG, Tan E, Attwood PV. Mammalian protein histidine kinases. Int. J. Biochem. Cell Biol. 2003 35: 297-309.
196. Bernard DJ, Chapman SC, Woodruff TK. Mechanisms of inhibin signal transduction. Recent Prog Horm Res. 2001 56:417-450.
197. Brunet S, Maro B. Cytoskeleton and cell cycle control during meiotic maturation of the mouse oocyte: integrating time and space. Reproduction. 2005 130:801-811.
198. Cheadle C, Nesterova M, Watkins T, Barnes KC, Hall JC, Rosen A, Becker KG, Cho-Chung YS. Regulatory subunits of PKA define an axis of cellular proliferation/differentiation in ovarian cancer cells. BMC Med Genomics. 2008 1:43.
199. Chrenek P, Grossmann R, Sirotkin AV. The cAMP analogue, dbcAMP affects release of steroid hormones by cultured rabbit ovarian cells and their response to FSH, IGF-I and ghrelin. Eur J Pharmacol. 2010 [Epub ahead of print, PubMed PMID: 20417631].
200. Conti M. Specificity of the cyclic adenosine 3",5"-monophosphate signal in granulosa cell function. Biol. Reprod. 2002, 67:1653-1661.
201. Dekel N. Cellular, biochemical and molecular mechanisms regulating oocyte maturation. Mol Cell Endocrinol. 2005 234:19-25.
202. Dhanasekaran N, Premkumar Reddy E. Signaling by dual specificity kinases. Oncogene 1998, 17: 1447-1455.
203. Diaz FJ, Anderson LE, Wu YL, Rabot A, Tsai SJ, Wiltbank MC. Regulation of progesterone and prostaglandin F2alpha production in the CL. Mol Cell Endocrinol. 2002 191:65-80.
204. Ducibella T, Fissore R. The roles of Ca2+, downstream protein kinases, and oscillatory signaling in regulating fertilization and the activation of development. Dev Biol. 2008 315:257-279.
205. Dupont J, Chabrolle C, Ramé C, Tosca L, Coyral-Castel S. Role of the peroxisome proliferator-activated receptors, adenosine monophosphate-activated kinase, and adiponectin in the ovary. PPAR Res. 2008; 2008:176275.
206. Fan HY, Sun QY. Involvement of mitogen-activated protein kinase cascade during oocyte maturation and fertilization in mammals. Biol Reprod. 2004 70535-547.
207. Fields AP, Regala RP. Protein kinase C iota: human oncogene, prognostic marker and therapeutic target. Pharmacol Res. 2007, 55:487-497.
208. Findlay JK, Drummond AE, Dyson M, Baillie AJ, Robertson DM, Ethier JF. Production and actions of inhibin and activin during folliculogenesis in the rat. Mol Cell Endocrinol. 2001 180:139-144.
209. Gadsby J, Rose L, Sriperumbudur R, Ge Z. The role of intra-luteal factors in the control of the porcine corpus luteum. Soc Reprod Fertil Suppl. 2006;62:69-83.
210. Gérard N, Caillaud M, Martoriati A, Goudet G, Lalmanach AC. The interleukin-1 system and female reproduction. J Endocrinol. 2004 180:203-212.
211. Gray D, Jubb AM, Hogue D, Dowd P, Kljavin N, Yi S, Bai W, Frantz G, Zhang Z, Koeppen H, de Sauvage FJ, Davis DP. Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers. Cancer Res. 2005 65:9751-9761.
212. Grøndahl C. Oocyte maturation. Basic and clinical aspects of in vitro maturation (IVM) with special emphasis of the role of FF-MAS. Dan Med Bull. 2008 55:1-16.
213. Hardeland R. Melatonin: signaling mechanisms of a pleiotropic agent. Biofactors. 2009 35:183-192.
214. Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol. 2001 179:39-46.
215. Hillier SG, Tetsuka M. Role of androgens in follicle maturation and atresia. Baillieres Clin Obstet Gynaecol. 1997 11:249-260.
216. Hsueh AJ, Eisenhauer K, Chun SY, Hsu SY, Billig H. Gonadal cell apoptosis. Recent Prog Horm Res. 1996 51:433-455.
217. Hua VK, Fleming SD, Illingworth P. Effects of protein kinase A and C inhibitors on follicular inhibin and activin during ovulation. Reprod Biomed Online. 2008 17:642-651.
218. Hunzicker-Dunn M, Maizels ET. FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal. 2006 18:1351-1359
219. Ingman WV, Jones RL. Cytokine knockouts in reproduction: the use of gene ablation to dissect roles of cytokines in reproductive biology. Hum Reprod Update. 2008 14:179-192.
220. Kamath S, Buolamwini JK. Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development. Med Res Rev. 2006 26:569-594.
221. Kimura N, Hoshino Y, Totsukawa K, Sato E. Cellular and molecular events during oocyte maturation in mammals: molecules of cumulus-oocyte complex matrix and signalling pathways regulating meiotic progression. Soc Reprod Fertil Suppl. 2007 63:327-42.
222. Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction. 2006 132:191-206.
223. Kowluru A. Identification and characterization of a novel protein histidine kinase in the islet beta cell: evidence for its regulation by mastoparan, an activator of G-proteins and insulin secretion". Biochem. Pharmacol. 2002 63: 2091-2100.
224. Kumar SR, Masood R, Spannuth WA, Singh J, Scehnet J, Kleiber G, Jennings N, Deavers M, Krasnoperov V, Dubeau L, Weaver FA, Sood AK, Gill PS. The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. Br J Cancer. 2007 96:1083-1091.
225. Lane D, Robert V, Grondin R, Rancourt C, Piché A. Malignant ascites protect against TRAIL-induced apoptosis by activating tle PI3K/Akt pathway in human ovarian carcinoma cells. Int J Cancer. 2007 121:1227-1237.
226. LaPolt PS, Leung K, Ishimaru R, Tafoya MA, You-hsin Chen J. Roles of cyclic GMP in modulating ovarian functions. Reprod Biomed Online. 2003 6:15-23.
227. Lefèvre B, Pesty A, Courtot AM, Martins CV, Broca O, Denys A, Arnault E, Poirot C, Avazeri N. The phosphoinositide-phospholipase C (PI-PLC) pathway in the mouse oocyte. Crit Rev Eukaryot Gene Expr. 2007 17:259-269.
228. Ma Y, Yu WD, Kong RX, Trump DL, Johnson CS. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated dinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells. Cancer Res. 2006 66:8131-8138.
229. Macarulla T, Ramos FJ, Tabernero J. Aurora kinase family: a new target for anticancer drug. Recent Patents Anticancer Drug Discov. 2008 3:114-122.
230. Makarevich A, Sirotkin A, Taradajnik T, Chrenek P. Effects of genistein and lavendustin on reproductive processes in domestic animals in vitro. J Steroid Biochem Mol Biol. 1997 63:329-37.
231. Makarevich A, Sirotkin A, Chrenek P, Bulla J, Hetenyi L. The role of IGF-I, cAMP/protein kinase A and MAP-kinase in the control of steroid secretion, cyclic nucleotide production, granulosa cell proliferation and preimplantation embryo development in rabbits. J Steroid Biochem Mol Biol. 2000 73:123-133.
232. Makarevich AV, Sirotkin AV, Chrenek P, Bulla J. Effect of epidermal growth factor (EGF) on steroid and cyclic nukleotide secretion, proliferation and ERK-related MAP-kinase in cultured rabbit granulosa cells. Exp Clin Endocrinol Diabetes. 2002 110:124-129.
233. Makarevich AV, Sirotkin AV, Genieser HG. Action of protein kinase A regulators on secretory activity of porcine granulosa cells in vitro. Anim Reprod Sci. 2004a 81:125-136.
234. Makarevich AV, Sirotkin AV, Franek J, Kwon HB, Bulla J. The role of oxytocin, protein kinase A, and ERK-related MAP-kinase in the control of porcine ovarian follicle functions. Exp Clin Endocrinol Diabetes. 2004b 112:108-114.
235. Manning G. Genomic overview of protein kinases. WormBook. 2005 13:1-19.
236. Markman M. The promise and perils of 'targeted therapy' of advanced ovarian cancer. Oncology. 2008 74:1-6.
237. Martin L, Schilder RJ. Novel non-cytotoxic therapy in ovarian cancer: current status and future prospects. J Natl Compr Canc Netw. 2006 4:955-66.
238. Masciarelli S, Horner K, Liu C, Park SH, Hinckley M, Hockman S, Nedachi T, Jin C, Conti M, Manganiello V. Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of fiale infertility. J Clin Invest. 2004 114:196-205.
239. Matousek M, Mikuni M, Mitsube K, Yoshida M, Brännström M. Inhibition of ovulation by tyrosine kinase inhibitors in the in vitro perfused rat ovary. J Reprod Fertil. 1999 117:379-385.
240. McKenna S.D., Pietropaolo M., Tos E.G., Clark A., Fischer D, Kagan D., Bao, B., Chedrese P.J., Palmer S. Pharmacological inhibition of phosphodiesterase 4 triggers ovulation in follicle-stimulating hormone-primed rats. Endocrinology, 2005 146: 208-214.
241. McLaughlin EA, McIver SC. Awakening the oocyte: controlling primordial follicle development. Reproduction. 2009 137:1-11.
242. Meidan R, Levy N, Kisliouk T, Podlovny L, Rusiansky M, Klipper E. The yin and yang of corpus luteum-derived endothelial cells: balancing life and death. Domest Anim Endocrinol. 2005 29:318-328.
243. Mermillod P, Dalbiès-Tran R, Uzbekova S, Thélie A, Traverso JM, Perreau C, Papillier P, Monget P. Factors affecting oocyte quality: who is driving the follicle? Reprod Domest Anim. 2008 43 Suppl 2:393-400.
244. Motola S, Cao X, Ashkenazi H, Popliker M, Tsafriri A. GnRH actions on rat preovulatory follicles are mediated by paracrine EGF-like factors. Mol Reprod Dev. 2006 73:1271-1276.
245. Niswender GD. Molecular control of luteal secretion of progesterone. Reproduction. 2002 123:333-339
246. Noske A, Kaszubiak A, Weichert W, Sers C, Niesporek S, Koch I, Schaefer B, Sehouli J, Dietel M, Lage H, Denkert C. Specific inhibition of AKT2 by RNA interference results in reduction of ovaria cancer cell proliferation: increased expression of AKT in advanced ovarian cancer. Cancer Lett. 2007 246:190-200.
247. Orihuela PA, Parada-Bustamante A, Cortés PP, Gatica C, Croxatto HB. Estrogen receptor, cyclic adenosine monophosphate, and protein kinase A are involved in the nongenomic pathway by which estradiol accelerates oviductal oocyte transport in cyclic rats. Biol Reprod. 2003 68:1225-1231.
248. Park CM, Kim SH, Kim SH, Moon MH, Kim KW, Choi HJ. Recurrent ovarian malignancy: patterns and spectrum of imaging findings. Abdom Imaging. 2003 28:404-415.
249. Peegel H, Towns R, Nair A, Menon KM. A novel mechanism for the modulation of luteinizing hormone receptor mRNA expression in the rat ovary. Mol Cell Endocrinol. 2005 233:65-72.
250. Peluso JJ. Multiplicity of progesterone's actions and receptors in the mammalian ovary. Biol Reprod. 2006 75:2-8.
251. Pierre A, Pisselet C, Dupont J, Mandon-Pépin B, Monniaux D, Monget P, Fabre S. Molecular basis of bone morphogenetic protein-4 inhibitory action on progesterone secretion by ovine granulosa cells. J Mol Endocrinol. 2004 33:805-817.
252. Ramakrishnappa N, Rajamahendran R, Lin YM, Leung PC. GnRH in non-hypothalamic reproductive tissues. Anim Reprod Sci. 2005 88:95-113.
253. Richards JS, Russell DL, Ochsner S, Hsieh M, Doyle KH, Falender AE, Lo YK, Sharma SC. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res. 2002 57:195-220.
254. Sawada K, Radjabi AR, Shinomiya N, Kistner E, Kenny H, Becker AR,Turkyilmaz MA,Salgia R, Yamada SD, Vande Woude GF, Tretiakova MS, Lengyel E. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res. 2007 67:1670-1679.
255. Seow KM, Juan CC, Hsu YP, Hwang JL, Huang LW, Ho LT. Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery. Hum Reprod. 2007 22:1003-1010.
256. Shimada M, Zeng WX, Terada T. Inhibition of phosphatidylinositol 3-kinase or mitogen-activated protein dinase kinase leads to suppression of p34(cdc2) kinase activity and meiotic progression beyond the meiosis I stage in porcine oocytes surrounded with cumulus cells. Biol Reprod. 2001 65:442-448.
257. Sirotkin AV. Control of reproductive processes by growth hormone: extra- and intracellular mechanisms. Vet J. 2005 170:307-317.
258. Sirotkin AV, Grossmann R. Role of tyrosine kinase- and MAP kinase-dependent intracellular mechanisms in control of ovarian functions in the domestic fowl (Gallus domesticus) and in mediating effects of IGF-II. J Reprod Dev. 2003 49:99-106.
259. Sirotki AV, Grossmann R. The role of protein kinase A and cyclin-dependent (CDC2) kinase in the control of basal and IGF-II-induced proliferation and secretory activity of chicken ovarian cells. Animal Reprod. Sci. 2006 92:169-181.
260. Sirotkin AV, Grossmann R. The involvement of leptin, MAP kinase- and CDC2 kinase-dependent intracellular mechanisms in the control of hormone release by chicken ovarian granulosa cells. Slovak J. Animal Sci. 41:6-11 (2007a)
261. Sirotkin AV, Grossmann R. The role of ghrelin and some intracellular mechanisms in controlling tle secretory activity of chicken ovarian cells. Comp Biochem Physiol A Mol Integr Physiol. 2007b 147:239-246.
262. Sirotkin AV, Makarevich AV. GH regulates secretory activity and apoptosis in cultured bovine granulosa cells through the activation of the cAMP/protein kinase A system. J Endocrinol. 1999 163:317-327.
263. Sirotkin AV, Makarevich AV Growth hormone can regulate functions of porcine ovarian granulosa cells through the cAMP/protein kinase A system. Anim Reprod Sci. 2002 70:111-126.
264. Sirotkin AV, Makarevich AV, Pivko J, Kotwica J, Genieser H, Bulla J. Effect of cGMP analogues and protein kinase G blocker on secretory activity, apoptosis and the cAMP/protein kinase A system in porcine ovarian granulosa cells in vitro. J Steroid Biochem Mol Biol. 2000a 74:1-9.
265. Sirotkin AV, Makarevich AV, Genieser HG, Kotwica J, Hetényi L. Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro. Exp Clin Endocrinol Diabetes. 2000b 108:214-219.
266. Sirotkin AV, Dukesová J, Makarevich AV, Kubek A, Bulla J. Evidence that growth factors IGF-I, IGF-II and EGF can stimulate nuclear maturation of porcine oocytes via intracellular protein kinase A. Reprod Nutr Dev. 2000c 40:559-569.
267. Sirotkin AV, Chrenek P., Curlej J., Zahradnikova M. Effect of 3-isobutyl-methyl-xanthine on rabbit superovulation and egg recovery. Slovak J. Animal Sci. 2008a 41:57-59.
268. Sirotkin AV, Mlyncek M, Makarevich AV, Florkovicová I, Hetényi L. Leptin affects proliferation-, apoptosis- and protein kinase A-related peptides in human ovarian granulosa cells. Physiol Res. 2008b 57:437-442.
269. Sirotkin AV, Ovcharenko D, Benco A, Mlyncek M. Protein kinases controlling PCNA and p53 expression in human ovarian cells. Funct Integr Genomics. 2009a 9:185-195.
270. Sirotkin AV, Chadio S, Chrenek P, Xylouri E, Fotopouloy H. Phosphodiesterase inhibitor 3-isobutyl-methyl-xanthine affects reproductive function in rabbit females. I. Stimulation of reproduction. Theriogenology. 2009b [Epub ahead of print, PubMed PMID: 19879640].
271. Sirotkin AV, Ovcharenko D, Mlyncek M. Identification of protein kinases that control ovarian hormone release by selective siRNAs. Mol. Cell Endocrinol. 2010 44:45-53.
272. Skinner MK. Regulation of primordial follicle assembly and development. Human Reproduction Update 2005 11:461-471.
273. Spaczynski RZ, Tilly JL, Mansour A, Duleba AJ. Insulin and insulin-like growth factors inhibit and luteinizing hormone augments ovarian theca-interstitial cell apoptosis. Mol Hum Reprod. 2005 11:319-324.
274. Stouffer RL, Xu F, Duffy DM. Molecular control of ovulation and luteinization in the primate follicle. Front Biosci. 2007 12:297-307.
275. Suga S, Kato K, Ohgami T, Yamayoshi A, Adachi S, Asanoma K, Yamaguchi S, Arima T, Kinoshita K, Wake N. An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer. Gynecol Oncol. 2007 105:341-350.
276. Suzuki K, Hayashi T. Protein C and its inhibitor in malignancy. Semin Thromb Hemost. 2007 33:667-72.
277. Tamura M, Nakagawa Y, Shimizu H, Yamada N, Miyano T, Miyazaki H. Cellular functions of mitogen-activated protein kinases and protein tyroxine phosphatases in ovarian granulosa cells. J Reprod Dev. 2004 50:47-55.
278. Viegas LR, Hoijman E, Beato M, Pecci A. Mechanisms involved in tissue-specific apopotosis regulated by glucocorticoids. J Steroid Biochem Mol Biol. 2008 109:273-278.
279. Wang H, Tsang BK. Nodal signalling and apoptosis. Reproduction. 2007 133:847-853.
280. Wang Z, Shi F, Jiang YQ, Lu LZ, Wang H, Watanabe G, Taya K. Changes of cyclic AMP levels and phosphodiesterase activities in the rat ovary. J Reprod Dev. 2007 53:717-725.
281. Xu G, Zhou H, Wang Q, Auersperg N, Peng C. Activin receptor-like kinase 7 induces apoptosis through up-regulation of Bax and down-regulation of Xiap in normal and malignant ovarian epithelial cell lines. Mol Cancer Res. 2006 4:235-246.
282. Zeng P, Wagoner HA, Pescovitz OH, Steinmetz R. RNA interference (RNAi) for extracellular signal-regulated kinase 1 (ERK1) alone is sufficient to suppress cell viability in ovarian cancer cells. Cancer Biol Ther. 2005 4:961-967.
283. Alam H, Weck J, Maizels E, Park Y, Lee EJ, Ashcroft M, Hunzicker-Dunn M. Role of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone. Endocrinology 2009 150:915-928.
284. Anttonen M, Parviainen H, Kyrönlahti A, Bielinska M, Wilson DB, Ritvos O,Heikinheimo M. GATA-4 is a granulosa cell factor employed in inhibin-alpha activation by the TGF-beta pathway. J Mol Endocrinol. 2006 36:557-568.
285. Benayoun BA, Kalfa N, Sultan C, Veitia RA. The forkhead factor FOXL2: a novel tumor suppressor? Biochim Biophys Acta 2010 1805:1-5.
286. Benco A, Sirotkin AV, Vašicek D, Pavlová S, Zemanová J, Kotwica J, Darlak K, Valenzuela F. Involvement of the transcription factor STAT1 in the regulation of porcine ovarian granulosa cell functions treated and not treated with ghrelin Reproduction 2009 138: 553-560.
287. Beysen D, De Paepe A, De Baere E. FOXL2 mutations and genomic rearrangements in BPES. Hum Mutat. 2009 30:158-169.
288. Boulton SJ. Cellular functions of the BRCA tumour-suppressor proteins. Biochem Soc Trans. 2006 34:633-645.
289. Brivanlou AH, Darnell JE. Signal transduction and the control of gene expression. Science 2002 295: 813-818
290. Chang MC, Vargas SO, Hornick JL, Hirsch MS, Crum CP, Nucci MR. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors. Int J Gynecol Pathol. 2009 28:347-355.
291. Chen YJ, Hsiao PW, Lee MT, Mason JI, Ke FC, Hwang JJ. Interplay of PI3K and cAMP/PKA signaling, and rapamycin-hypersensitivity in TGFbeta1 enhancement of FSH-stimulated steroidogenesis in rat ovarian granulosa cells. J Endocrinol. 2007 192:405-419.
292. Choi Y, Rajkovic A. Genetics of early mammalian folliculogenesis. Cell Mol Life Sci. 2006 63:579-590.
293. Corney DC, Nikitin AY. MicroRNA and ovarian cancer. Histol Histopathol. 2008 23:1161-1169.
294. Coutts SM, Childs AJ, Fulton N, Collins C, Bayne RA, McNeilly AS, Anderson RA. Activin signals via SMAD2/3 between germ and somatic cells in the human fetal ovary and regulates kit ligand expression. Dev Biol. 2008 314:189-199.
295. Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 2006 34:1416-1426.
296. Diaz FJ, Wigglesworth K, Eppig JJ. Oocytes determine cumulus cell lineage in mouse ovarian follicles. J Cell Sci 2007 120(Pt 8):1330-1340.
297. Duncan WC, van den Driesche S, Fraser HM. Inhibition of vascular endothelial growth factor in the primate ovary up-regulates hypoxia-inducible factor-1alpha in the follicle and corpus luteum. Endocrinology. 2008 149:3313-3320.
298. Eo J, Han K, M Murphy K, Song H, Lim HJ. Etv5, an ETS transcription factor, is expressed in granulosa and cumulus cells and serves as a transcriptional regulator of the cyclooxygenase-2. J Endocrinol. 2008 198:281-290.
299. Ghafari F, Pelengaris S, Walters E, Hartshorne GM. Influence of p53 and genetic background on prenatal oogenesis and oocyte attrition in mice. Hum Reprod. 2009 24:1460-1472.
300. Gonzalez-Navarrete, F., Eisner, V., Morales, P., Castro, O., Pommer, R., Quiroga, C., Lavandero, S., Devoto, L. (2007) Tumor necrosis factor-alpha activates nuclear factor-kappaB but does not regulate progesterone production in cultured human granulosa luteal cells. Gynecol Endocrinol 2007 23:377-384.
301. He PJ, Hirata M, Yamauchi N, Hashimoto S, Hattori MA. Gonadotropic regulation of circadian clockwork in rat granulosa cells. Mol Cell Biochem. 2007 302:111-118.
302. Huang F, Tong X, Fu L, Zhang R. Knockdown of STAT3 by shRNA inhibits the growth of CAOV3 ovarian cancer cell line in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai). 2008 40:519-525.
303. Hunzicker-Dunn M, Maizels ET. FSH signaling pathways in immature granulosa cells that regulate target gene expression: Branching out from protein kinase A. Cell Signal. 2006 18: 1351-1359.
304. Jin S. p53, Autophagy and tumor suppression. Autophagy. 2005 1:171-173.
305. Kaivo-oja N, Jeffery LA, Ritvos O, Mottershead DG. Smad signalling in the ovary. Reprod Biol Endocrinol. 2006 4:21.
306. Kim H, Chen J. New players in the BRCA1-mediated DNA damage responsive pathway. Mol Cells. 2008 25:457-461.
307. Kim J, Bagchi IC, Bagchi MK. Signaling by hypoxia-inducible factors is critical for ovulation in mice. Endocrinology. 2009 150:3392-3400.
308. Kuo FT, Bentsi-Barnes IK, Barlow GM, Bae J, Pisarska MD. Sumoylation of Forkhead L2 by Ubc9 is required for its activity as a transcriptional repressor of the Steroidogenic Acute Regulatory gene. Cell Signal. 2009 21: 1935-1944.
309. Lafky JM, Wilken JA, Baron AT, Maihle NJ. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta. 2008 1785:232-265.
310. Li Q, Pangas SA, Jorgez CJ, Graff JM, Weinstein M, Matzuk MM. Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. Mol Cell Biol. 2008a 28:7001-7011.
311. Li YF, Hu W, Fu SQ, Li JD, Liu JH, Kavanagh JJ. Aromatase inhibitors in ovarian cancer: is there a role? Int J Gynecol Cancer. 2008b 18:600-614.
312. Li Q, Rajanahally S, Edson MA, Matzuk MM. Stable expression and characterization of N-terminal tagged recombinant human bone morphogenetic protein 15. Mol Hum Reprod.2009 15:779-788.
313. Linnerth NM, Greenaway JB, Petrik JJ, Moorehead RA. cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation. Int J Gynecol Cancer. 2008 18:1248-1257.
314. Mészárosová M, Sirotkin AV, Grossmann R, Darlak K, Valenzuela F. The effect of obestatin on porcine ovarian granulosa cells. Anim Reprod Sci. 2008 108:196-207.
315. Morales V, Gonzalez-Robayna I, Santana MP, Hernandez I, Fanjul LF. Tumor necrosis factor-alpha activates transcription of inducible repressor form of 3',5'-cyclic adenosine 5'-monophosphate-responsive element binding modulator and represses P450 aromatase and inhibin alpha-subunit expression in rat ovarian granulosa cells by a p44/42 mitogen-activated protein kinase-dependent mechanism. Endocrinology. 2006 147:5932-5939.
316. Mottershead DG, Pulkki MM, Muggalla P, Pasternack A, Tolonen M, Myllymaa S, Korchynskyi O, Nishi Y, Yanase T, Lun S, Juengel JL, Laitinen M, Ritvos O. Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells. Mol Cell Endocrinol. 2008 283:58-67.
317. Moumné L, Batista F, Benayoun BA, Nallathambi J, Fellous M, Sundaresan P, Veitia RA. The mutations and potential targets of the forkhead transcription factor FOXL2. Mol Cell Endocrinol. 2008 282:2-11.
318. Naidu KA, Fang Q, Naidu KA, Cheng JQ, Nicosia SV, Coppola D. P53 enhances ascorbyl stearate-induced G2/M arrest of human ovarian cancer cells. Anticancer Res. 2007 27:3927-3934.
319. Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002 108: 475-487.
320. Ottolenghi C, Colombino M, Crisponi L, Cao A, Forabosco A, Schlessinger D, Uda M. Transcriptional control of ovarian development in somatic cells. Semin Reprod Med. 2007 25:252-263.
321. Pangas SA, Li X, Robertson EJ, Matzuk MM. Premature luteinization and cumulus cell defects in ovarian-specific Smad4 knockout mice. Mol Endocrinol. 2006 20:1406-1422.
322. Pangas SA. Growth factors and ovarian development. Semin Reprod Med 2007;25:225-234.
323. Peluso JJ. Non-genomic actions of progesterone in the normal and neoplastic mammalian ovary. Semin Reprod Med. 2007 25:198-207.
324. Ren, M., Guan, Q., Zhong, X., Gong, B., Sun, Y., Xin, W., Guo, Y., Wang, H., Gao, L., Zhao, J. Phosphatidylinositol 3-kinase/nuclear factor-?B signaling pathway is involved in the regulation of IGF-I on Fas-associated death domain-like interleukin-1-converting enzyme-inhibitory protein expression in cultured FRTL thyroid cells. J Molec Endocr. 2007 38:619-625.
325. Sayasith K, Brown KA, Lussier JG, Doré M, Sirois J. Characterization of bovine early growth response factor-1 and its gonadotropin-dependent regulation in ovarian follicles prior to ovulation. J Mol Endocrinol. 2006 37:239-250.
326. Sharma D, Ghai S, Singh D. Different promoter usage for CYP19 gene expression in buffalo ovary and placenta. Gen Comp Endocrinol. 2009 162:319-328.
327. Simpson JL. Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Ann N Y Acad Sci. 2008 1135:146-154.
328. Sirotkin AV, Makarevich AV, Grossmann R, Kotwica J, Schaeffer H-J, Marnet P-G, Kwon H, Sanislo P, Florkovicova I, Petrak J, Rafal J, Pivko J, Hetenyi L. Regulators of ovarian function. In: "Regulation and Evaluation of Ovarian Function and Embryogenesis in Normal and Transgenic Animals in vitro and in vivo"(M.R. Luck ed.). Research Institute of Animal Production, Nitra, Slovakia, 2003, pp. 9-25.
329. Sirotkin AV, Grossmann R. Leptin directly controls proliferation, apoptosis and secretory activity of cultured chicken ovarian cells. Comp Biochem Physiol A Mol Integr Physiol. 2007 148:422-429.
330. Sirotkin AV, Grossmann R, María-Peon MT, Roa J, Tena-Sempere M, Klein S. Novel expression and functional role of ghrelin in chicken ovary. Mol Cell Endocrinol. 2006 257-258:15-25.
331. Sirotkin AV, Benco A, Tandlmajerova A, Vasícek D, Kotwica J, Darlak K, Valenzuela F. Transcription factor p53 can regulate proliferation, apoptosis and secretory activity of luteinizing porcine ovarian granulosa cell cultured with and without ghrelin and FSH. Reproduction. 2008 136:611-618.
332. Spicer LJ, Sudo S, Aad PY, Wang LS, Chun SY, Ben-Shlomo I, Klein C, Hsueh AJ. The hedgehog-patched signaling pathway and function in the mammalian ovary: a novel role for hedgehog proteins in stimulating proliferation and steroidogenesis of theca cells. Reproduction. 2009 138:329-339.
333. Stegmaier P, Kel AE, Wingender E. Systematic DNA. Genome informatics. International Conference on Genome Informatics 2004 15: 276-286.
334. Suzumori N, Pangas SA, Rajkovic A. Candidate genes for premature ovarian failure. Curr Med Chem. 2007 14:353-357.
335. Telleria, C.M., Goyeneche, A.A., Stocco, C.O., Gibori, G. Involvement of nuclear factor kappa B in the regulation of rat luteal function: potential roles as survival factor and inhibitor of 20alpha-hydroxysteroid dehydrogenase. J Molec Endocr 2004 2:365-383
336. Uhlenhaut NH, Treier M. Foxl2 function in ovarian development. Mol Genet Metab. 2006 88:225-234.
337. Walters, Allan CM, Handelsman DJ. Androgen actions and the ovary. Biol Reprod. 2008 78:380-389.
338. Wang H, Tsang BK. Nodal signalling and apoptosis. Reproduction. 2007 133:847-53.
339. Wen L, Craig J, Dyce PW, Li J. Cloning of porcine signal transducer and activator of transcription 3 cDNA and its expression in reproductive tissues. Reproduction. 2006 132:511-518.
340. Wilson D, Charoensawan V, Kummerfeld SK, Teichmann SA. DBD--taxonomically broad transcription factor predictions: new content and functionality. Nucleic Acids Res. 2008 36(Database issue):D88-D92.
341. Xiao, C.W., Asselin, E., Tsang, B.K. Nuclear factor kappaB-mediated induction of Flice-like inhibitory protein prevents tumor necrosis factor alpha-induced apoptosis in rat granulosa cells. Biol Reprod 2002 67:436-441
342. Zielak AE, Canty MJ, Forde N, Coussens PM, Smith GW, Lonergan P, Ireland JJ, Evans AC. Differential expression of genes for transcription factors in theca and granulosa cells following selection of a dominant follicle in cattle. Mol Reprod Dev. 2008 75:904-914.
343. Amarzguioui M, Rossi JJ, Kim D. Approaches for chemically synthesized siRNA and vector-mediated RNAi. FEBS Lett. 2005 579:5974-5981.
344. Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GA, Mukherjee P. MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer. Cancer Res. 2009 69:9090-9095.
345. Boldbaatar D, Battsetseg B, Matsuo T, Hatta T, Umemiya-Shirafuji R, Xuan X, Fujisaki K. Tick vitellogenin receptor reveals critical role in oocyte development and transovarial transmission of Babesia parasite. Biochem Cell Biol. 2008 86:331-344.
346. Bonnet A, Dalbiès-Tran R, Sirard MA. Opportunities and challenges in applying genomics to the study of oogenesis and folliculogenesis in farm animals. Reproduction. 2008 135:119-128.
347. Brotin E, Meryet-Figuière M, Simonin K, Duval RE, Villedieu M, Leroy-Dudal J, Saison-Behmoaras E, Gauduchon P, Denoyelle C, Poulain L. Bcl-x(L) and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis. Int J Cancer. 2010 126:885-895.
348. Bruegmann E, Gruemmer R, Neulen J, Motejlek K. Regulation of soluble vascular endothelial growth factor receptor 1 secretion from human endothelial cells by tissue inhibitor of metalloproteinase 1. Mol Hum Reprod. 2009 15:749-756.
349. Chan DW, Liu VW, To RM, Chiu PM, Lee WY, Yao KM, Cheung AN, Ngan HY. Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21(WAF1/CIP1) expression in ovarian cancer. Br J Cancer. 2009 101:1433-1443.
350. Choi Y, Qin Y, Berger MF, Ballow DJ, Bulyk ML, Rajkovic A. Microarray analyses of newborn mouse ovaries lacking Nobox. Biol Reprod. 2007 77:312-319.
351. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. 2007 MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 67:8433-8438.
352. Dahiya N, Morin P. MicroRNAs in Ovarian Carcinomas. Endocr Relat Cancer. 2010 17:F77-F89.
353. Donahue RN, McLaughlin PJ, Zagon IS. Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis. Am J Physiol Regul Integr Comp Physiol. 2009 296:R1716-R1725.
354. Doran T., Helliwell C (eds.) RNA Interference: Methods for Plants and Animals (Principles and Protocol Series). Cabi, 2008 272 pp.
355. Farazi TA, Juranek SA, Tuschl T. The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members. Development. 2008 135:1201-1214.
356. Fiedler SD, Carletti MZ, Hong X, Christenson LK. Hormonal regulation of MicroRNA expression in periovulatory mouse mural granulosa cells. Biol Reprod. 2008 79:1030-1037.
357. Forde N, Mihm M, Canty MJ, Zielak AE, Baker PJ, Park S, Lonergan P, Smith GW,Coussens PM, Ireland JJ, Evans AC. Differential expression of signal transduction factors in ovarian follicle development: a functional role for betaglycan and FIBP in granulosa cells in cattle. Physiol Genomics. 2008 33:193-204.
358. Frank-Kamenetsky M, Grefhorst A, Anderson NN, Racie TS, Bramlage B, Akinc A,Butler D, Charisse K, Dorkin R, Fan Y, Gamba-Vitalo C, Hadwiger P, Jayaraman M,John M, Jayaprakash KN, Maier M, Nechev L, Rajeev KG, Read T, Röhl I, Soutschek J, Tan P, Wong J, Wang G, Zimmermann T, de Fougerolles A, Vornlocher HP, Langer R, Anderson DG, Manoharan M, Koteliansky V, Horton JD, Fitzgerald K. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci U S A. 2008 105:11915-11920.
359. Hasegawa A, Koyama K. Contribution of zona proteins to oocyte growth. Soc Reprod Fertil Suppl. 2007 63:229-235.
360. Huang F, Tong X, Fu L, Zhang R. Knockdown of STAT3 by shRNA inhibits the growth of CAOV3 ovarian cancer cell line in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai). 2008 40:519-525.
361. Huang Y, Hua K, Zhou X, Jin H, Chen X, Lu X, Yu Y, Zha X, Feng Y. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma. Cell Res. 2008 18:780-791.
362. Hui YY, Lavoie HA. GATA4 reduction enhances 3',5'-cyclic adenosine 5'-monophosphate-stimulated steroidogenic acute regulatory protein messenger ribonucleic acid and progesterone production in luteinized porcine granulosa cells. Endocrinology. 2008 149:5557-5567.
363. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Ménard S, Croce CM. 2007 MicroRNA signatures in human ovarian cancer. Cancer Res. 67:8699-8707.
364. Kaneda M, Tang F, O'Carroll D, Lao K, Surani MA. Essential role for Argonaute2 protein in mouse oogenesis. Epigenetics Chromatin. 2009 2:9.
365. Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI. Bioconjug Chem. 2008 19:2156-2162.
366. Kobayashi S, Sakatani M, Kobayashi S, Okuda K, Takahashi M. Gene silencing of cyclooxygenase-2 mRNA by RNA interference in bovine cumulus-granulosa cells. J Reprod Dev. 2007 53:1305-1311.
367. Kulkarni AA, Kingsbury SR, Tudzarova S, Hong HK, Loddo M, Rashid M, Rodriguez-Acebes S, Prevost AT, Ledermann JA, Stoeber K, Williams GH. Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma. Clin Cancer Res. 2009 15:2417-2425.
368. Lei L, Jin S, Gonzalez G, Behringer RR, Woodruff TK. The regulatory role of Dicer in folliculogenesis in mice. Mol Cell Endocrinol. 2010 315:63-73.
369. Li Y, Liang XY, Wei LN, Xiong YL, Yang X, Shi HG, Yang ZH. Study of RNA interference inhibiting rat ovarian androgen biosynthesis by depressing 17alpha-hydroxylase/17, 20-lyase activity in vivo. Reprod Biol Endocrinol. 2009 7:73.
370. Linnerth NM, Greenaway JB, Petrik JJ, Moorehead RA. cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation. Int J Gynecol Cancer. 2008 18:1248-1257.
371. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One. 2009 4:e6229.
372. Lu HL, Vinson SB, Pietrantonio PV. Oocyte membrane localization of vitellogenin receptor coincides with queen flying age, and receptor silencing by RNAi disrupts egg formation in fire ant viržin queens. FEBS J. 2009 276:3110-3123.
373. Lu YM, Zhang SL, Meng LR, Zhao YY. Influence of human epidermal growth factor receptor-2 siRNA on chemosensitivity to cisplatin of human ovarian carcinoma cells: an in vitro experiment. Zhonghua Yi Xue Za Zhi. 2008 88:909-913.
374. Ma JJ, Chen BL, Xin XY. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma. Eur J Obstet Gynecol Reprod Biol. 2009 146:222-226.
375. Mancini F, Di Conza G, Pellegrino M, Rinaldo C, Prodosmo A, Giglio S, D'Agnano I, Florenzano F, Felicioni L, Buttitta F, Marchetti A, Sacchi A, Pontecorvi A, Soddu S, Moretti F. MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J. 2009 28:1926-1939.
376. Mangala LS, Han HD, Lopez-Berestein G, Sood AK. Liposomal siRNA for ovarian cancer. Methods Mol Biol. 2009 555:29-42.
377. Mattiske DM, Han L, Mann JR. Meiotic maturation failure induced by DICER1 deficiency is derived from primary oocyte ooplasm. Reproduction. 2009 137:625-632.
378. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, Deavers MT, Mourad-Zeidan A, Wang H, Mueller P,Lenburg ME, Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M, Sood AK. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med. 2008 359:2641-2450.
379. Murchison EP, Stein P, Xuan Z, Pan H, Zhang MQ, Schultz RM, Hannon GJ. Critical roles for Dicer in the female germline. Genes Dev. 2007 21:682-693
380. Nagaraja AK, Andreu-Vieyra C, Franco HL, Ma L, Chen R, Han DY, Zhu H, Agno JE, Gunaratne PH, DeMayo FJ, Matzuk MM. Deletion of Dicer in somatic cells of the female reproductive tract causes sterility. Mol Endocrinol. 2008 22:2336-2352.
381. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW, Kim S. MicroRNA expression profiles in servus ovarian carcinoma. Clin Cancer Res. 2008, 14:2690-2695.
382. Oktay K, Buyuk E, Oktem O, Oktay M, Giancotti FG. The c-Jun N-terminal kinase JNK functions upstream of Aurora B to promote entry into mitosis. Cell Cycle. 2008 7:533-541.
383. Otsuka M, Zheng M, Hayashi M, Lee JD, Yoshino O, Lin S, Han J. Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. J Clin Invest. 2008 118:1944-1954.
384. Paragh G, Kumar SM, Rakosy Z, Choi SC, Xu X, Acs G. RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells. Am J Pathol. 2009 174:1504-1514.
385. Pierre P, Froment P, Nègre D, Ramé C, Barateau V, Chabrolle C, Lecomte P, Dupot J. Role of adiponectin receptors, AdipoR1 and AdipoR2, in the steroidogenesis of tle human granulosa tumor cell line, KGN. Hum Reprod. 2009 24:2890-2891.
386. Rahbek UL, Howard KA, Oupicky D, Manickam DS, Dong M, Nielsen AF, Hansen TB, Besenbacher F, Kjems J. Intracellular siRNA and precursor miRNA trafficking using bioresponsive copolypeptides. J Gene Med. 2008 10:81-93.
387. Rayhman O, Klipper E, Muller L, Davidson B, Reich R, Meidan R. Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells. Cancer Res. 2008 68:9265-9273.
388. Ro S, Song R, Park C, Zheng H, Sanders KM, Yan W. 2007 Cloning and expression profiling of small RNAs expressed in the mouse ovary. RNA. 13:2366-2380.
389. Seto, A.G., R.E. Kingston, and N.C. Lau. The coming of age for piwi proteins. Molecular Cell 2007 26: 603-609.
390. Shen XH, Han YJ, Zhang DX, Cui XS, Kim NH. A link between the interleukin-6/Stat3 anti-apoptotic pathway and microRNA-21 in preimplantation mouse embryos. Mol Reprod Dev. 2009 76:854-862.
391. Shin JS, Hong SW, Lee SL, Kim TH, Park IC, An SK, Lee WK, Lim JS, Kim KI, Yang Y, Lee SS, Jin DH, Lee MS. Serum starvation induces G1 arrest through suppression of Skp2-CDK2 and CDK4 in SK-OV-3 cells. Int J Oncol. 2008 32:435-439.
392. Silveri L, Tilly G, Vilotte JL, Le Provost F. 2006 MicroRNA involvement in mammary gland development and breast cancer. Reprod Nutr Dev. 46:549-556.
393. Sirotkin AV, Ovcharenko D, Grossmann R, Lauková M, Mlyncek M. Identification of microRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen. J Cell Physiol. 2009a 219:415-420.
394. Sirotkin AV, Ovcharenko D, Benco A, Mlyncek M. Protein kinases controlling PCNA and p53 expression in human ovaria cells. Funct. Integr. Genomics 2009b 9:185-195.
395. Sirotkin AV, Lauková M, Ovcharenko D, Brenaut P, Mlyncek M. Identification of microRNAs controlling human ovarian cell proliferation and apoptosis. J. Cell Physiol 2010a 223:49-56.
396. Sirotkin AV, Ovcharenko D, Mlyncek M. Identification of protein kinases that control ovarian hormone release by selective siRNAs. J. Molec. Endocrinol 2010b 44:45-53.
397. Stefani G, Slack F. 2006 MicroRNAs in search of a target. Cold Spring Harb Symp Quant Biol. 71:129-134.
398. Svoboda P. RNA silencing in mammalian oocytes and early embryos. Curr Top Microbiol Immunol. 2008 320:225-56.
399. Tam OH, Aravin AA, Stein P, Girard A, Murchison EP, Cheloufi S, Hodges E, Anger M, Sachidanandam R, Schultz RM, Hannon GJ. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature. 2008 453:534-538.
400. Tang F, Kaneda M, O'Carroll D, Hajkova P, Barton SC, Sun, Lee C, Tarakhovsky A, Lao K, Surani MA. Maternal microRNAs are essential for mouse zygotic development. Genes Dev. 2007 21:644-648.
401. Tang F, Barbacioru C, Wang Y, Nordman E, Lee C, Xu N, Wang X, Bodeau J, Tuch BB, Siddiqui A, Lao K, Surani MA. mRNA-Seq whole-transcriptome analysis of a single cell. Nat Methods. 2009 6:377-382.
402. Tesfaye D, Worku D, Rings F, Phatsara C, Tholen E, Schellander K, Hoelker M. Identification and expression profiling of microRNAs during bovine oocyte maturation using heterologous approach. Mol Reprod Dev. 2009 76:665-677.
403. Thompson AJ, Patel K. Antisense inhibitors, ribozymes, and siRNAs. Clin Liver Dis. 2009 13:375-390.
404. Tian L, Wu Z, Zhao Y, Meng Y, Si Y, Fu X, Mu Y, Han W. Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells. J Endocrinol. 2009 202:167-177.
405. Todd MC, Spruill SC, Meerbrey KL. Small interference RNA-mediated suppression of overexpressed cyclin E protein restores G1/S regulation in NIH-OVCAR-3 ovarian cancer cells. Int J Oncol. 2009 35:375-380.
406. Toloubeydokhti T, Bukulmez O, Chegini N. Potential regulatory functions of microRNAs in the ovary. Semin Reprod Med. 2008 26:469-c78.
407. Tsuda N, Kawano K, Efferson CL, Ioannides CG. 2005 Synthetic microRNA and double-stranded RNA targeting the 3'-untranslated region of HER-2/neu mRNA inhibit HER-2 protein expression in ovarian cancer cells. Int J Oncol. 27:1299-1306.
408. Tsuno T, Mejido J, Zhao T, Schmeisser H, Morrow A, Zoon KC. IRF9 is a Key Factor for Eliciting the Antiproliferative Activity of IFN-alpha. J Immunother. 2009 Sep 11. [Epub ahead of print]
409. Wang C, Xu B, Zhou B, Zhang C, Yang J, Ouyang H, Ning G, Zhang M, Shen J, Xia G. Reducing CYP51 inhibits FSH-induced resumption of mouse oocyte meiosis in vitro. J Lipid Res. 2009 May 11. [Epub ahead of print] PMID: 19433477
410. Wang FQ, Barfield E, Dutta S, Pua T, Fishman DA. VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion. Gynecol Oncol. 2009 Sep 16. [Epub ahead of print]
411. Wang Y, Lee CG. MicroRNA and cancer--focus on apoptosis. J Cell Mol Med. 2009 13:12-23.
412. Watanabe T, Takeda A, Tsukiyama T, Mise K, Okuno T, Sasaki H, Minami N, Imai H. Identification and characterization of two novel classes of small RNAs in the mouse germline: retrotransposon-derived siRNAs in oocytes and germline small RNAs in testes. Genes Dev. 2006 20:1732-1743.
413. Watanabe T, Totoki Y, Toyoda A, Kaneda M, Kuramochi-Miyagawa S, Obata Y, Chiba H, Kohara Y, Kono T, Nakano T, Surani MA, Sakaki Y, Sasaki H. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature. 2008 453:539-543.
414. Witham J, Valenti MR, De-Haven-Brandon AK, Vidot S, Eccles SA, Kaye SB, Richardson A. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin. Clin Cancer Res. 200713:7191-7198.
415. Wu S-C. RNA interference technology to improve recombinant protein production in Chinese hamster ovary cells. Biotechnology Advances 2009 27: 417-422.
416. Yotsumoto F, Yagi H, Suzuki SO, Oki E, Tsujioka H, Hachisuga T, Sonoda K, Kawarabayashi T, Mekada E, Miyamoto S. Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem Biophys Res Commun. 2008 365:555-561.
417. Yu J-Y, DeRuiter SL, and Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 2002 99:6047-6052.
418. Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 2007 302:1-12.
419. Zhang X, Deng HX, Zhao X, Su D, Chen XC, Chen LJ, Wei YQ, Zhong Q, Li ZY, He X, Yi T. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitro and in vivo. Oncology. 2009;77:22-32.
420. Zhou Y, Yi X, Stoffer JB, Bonafe N, Gilmore-Hebert M, McAlpine J, Chambers SK. The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer. Mol Cancer Res. 2008 6:1375-1384.
421. Brevini TA, Cillo F, Antonini S, Gandolfi F. Cytoplasmic remodelling and the acquisition of developmental competence in pig oocytes. Anim Reprod Sci. 2007 98:23-38.
422. Brunet S, Maro B. Cytoskeleton and cell cycle control during meiotic maturation of the mouse oocyte: integrating time and space. Reproduction. 2005 130:801-811.
423. Dekel N. Cellular, biochemical and molecular mechanisms regulating oocyte maturation. Mol Cell Endocrinol. 2005 234:19-25.
424. Ducibella T, Fissore R. The roles of Ca2+, downstream protein kinases, and oscillatory signaling in regulating fertilization and the activation of development. Dev Biol. 2008 315:257-279.
425. Fan HY, Sun QY. Involvement of mitogen-activated protein kinase cascade during oocyte maturation and fertilization in mammals. Biol Reprod. 2004 70535-547.
426. Gershon E, Plaks V, Dekel N. Gap junctions in the ovary: Expression, localization and function. Molec. Cell. Endocrinol. 2008, 282:18-25.
427. Gilchrist RB, Ritter LJ, Armstrong DT. Oocyte-somatic cell interactions during follicle development in mammals. Anim Reprod Sci. 82-83:431-446, 2004.
428. Grøndahl C. Oocyte maturation. Basic and clinical aspects of in vitro maturation (IVM) with special emphasis of the role of FF-MAS. Dan Med Bull. 2008 55:1-16.
429. Hunter MG. Oocyte maturation and ovum quality in pigs. Rev Reprod. 2000 5:122-130.
430. Lefèvre B, Pesty A, Courtot AM, Martins CV, Broca O, Denys A, Arnault E, Poirot C, Avazeri N. The phosphoinositide-phospholipase C (PI-PLC) pathway in the mouse oocyte. Crit Rev Eukaryot Gene Expr. 2007 17:259-269.
431. Lonergan P. State-of-the-art embryo technologies in cattle. Soc Reprod Fertil Suppl.64:315-325, 2007.
432. Makarevich A, Sirotkin A, Taradajnik T, Chrenek P. Effects of genistein and lavendustin on reproductive processes in domestic animals in vitro. J Steroid Biochem Mol Biol. 1997 63:329-37.
433. McLaughlin EA, McIver SC. Awakening the oocyte: controlling primordial follicle development. Reproduction. 2009 137:1-11.
434. Mermillod P, Dalbiès-Tran R, Uzbekova S, Thélie A, Traverso JM, Perreau C, Papillier P, Monget P. Factors affecting oocyte quality: who is driving the follicle? Reprod Domest Anim. 2008 43 Suppl 2:393-400.
435. Motola S, Cao X, Ashkenazi H, Popliker M, Tsafriri A. GnRH actions on rat preovulatory follicles are mediated by paracrine EGF-like factors. Mol Reprod Dev. 2006 73:1271-1276.
436. Sirotkin AV, Makarevich AV, Grossmann R, Kotwica J, Schaeffer H-J, Marnet P-G, Kwon H, Sanislo P, Florkovicova I, Petrak J, Rafal J, Pivko J, Hetenyi L. Regulators of ovarian function. In: "Regulation and Evaluation of Ovarian Function and Embryogenesis in Normal and Transgenic Animals in vitro and in vivo"(M.R. Luck ed.). Research Institute of Animal Production, Nitra, Slovakia, 2003, pp. 9-25.
437. van den Hurk R, Zhao J. Formation of mammalian oocytes and their growth, differentiation and maturation within ovarian follicles. Theriogenology. 2005 63:1717-1751.
438. Wang C, Xu B, Zhou B, Zhang C, Yang J, Ouyang H, Ning G, Zhang M, Shen J, Xia G. Reducing CYP51 inhibits FSH-induced resumption of mouse oocyte meiosis in vitro. J Lipid Res. 2009 50:2164-1272.
439. Adams GP, Jaiswal R, Singh J, Malhi P. Progress in understanding ovarian follicular dynamics in cattle. Theriogenology. 2008 69:72-80.
440. Berisha B, Schams D. Ovarian function in ruminants. Domest Anim Endocrinol. 2005 29:305-317.
441. Brännström M, Enskog A. Leukocyte networks and ovulation. J Reprod Immunol. 2002 57:47-60.
442. Bukulmez O, Arici A. Leukocytes in ovarian function. Hum Reprod Update. 2000 6:1-15.
443. Caixeta ES, Ripamonte P, Franco MM, Junior JB, Dode MA Effect of follicle size on mRNA expression in cumulus cells and oocytes of Bos indicus: an approach to identify marker genes for developmental competence. Reprod Fertil Dev. 2009 21:655-664.
444. Craig J, Orisaka M, Wang H, Orisaka S, Thompson W, Zhu C, Kotsuji F, Tsang BK. Gonadotropin and intra-ovarian signals regulating follicle development and atresia: the delicate balance between life and death. Front Biosci. 2007 12:3628-3639.
445. DiLuigi AJ, Nulsen JC. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function. Curr Opin Obstet Gynecol. 2007 19:258-265.
446. Diskin MG, Austin EJ, Roche JF. Exogenous hormonal manipulation of ovarian activity in cattle. Domest Anim Endocrinol. 2002 23:211-228.
447. Drummond AE. The role of steroids in follicular growth. Reprod Biol Endocrinol. 2006 4:16-27.
448. Espey LL, Bellinger AS, Healy JA. Ovulation: an inflammatory cascade of gene expression. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 145-165.
449. Fortune JE. The early stages of follicular development: activation of primordial follicles and growth of preantral follicles. Anim Reprod Sci. 2003 78:135-163.
450. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001 81:629-683.
451. Gougeon A. Dynamics of human follicular growth: morphologic, dynamic, and functional aspects. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 25-43.
452. Hrometz SL, Gates VA. Review of available infertility treatments. Drugs Today (Barc). 2009 45:275-291.
453. Ingman WV, Jones RL. Cytokine knockouts in reproduction: the use of gene ablation to dissect roles of cytokines in reproductive biology. Hum Reprod Update. 2008 14:179-192.
454. Kolibianakis EM, Papanikolaou EG, Fatemi HM, Devroey P. Estrogen and folliculogenesis: is one necessary for the other? Curr Opin Obstet Gynecol. 2005 17:249-253.
455. Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction. 2006 132:191-206.
456. Kucharski J, Jana B. Immuno-endocrine mechanisms connected with the creation of corpora lutea persistent in animal ovaries. Pol J Vet Sci. 2005 8:255-259.
457. Kumar TR. Functional analysis of LHbeta knockout mice. Mol Cell Endocrinol. 2007 269:81-84.
458. Lonergan P. State-of-the-art embryo technologies in cattle. Soc Reprod Fertil. 2007 Suppl.64:315-325
459. McNeilly AS. Lactation and fertility. J Mammary Gland Biol Neoplasia. 1997 2:291-298.
460. Mermillod P, Dalbiès-Tran R, Uzbekova S, Thélie A, Traverso JM, Perreau C, Papillier P, Monget P. Factors affecting oocyte quality: who is driving the follicle? Reprod Domest Anim. 2008 43 Suppl 2:393-400.
461. Mihm M, Evans AC. Mechanisms for dominant follicle selection in monovulatory species: a comparison of morphological, endocrine and intraovarian events in cows, mares and women. Reprod Domest Anim. 2008 43 Suppl 2:48-56.
462. Nilsson E, Rogers N, Skinner MK. Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction. 2007 134:209-221.
463. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev. 2000 80:1-29.
464. Otsuka F, Moore RK, Wang X, Sharma S, Miyoshi T, Shimasaki S. Essential role of the oocyte in estrogen amplification of follicle-stimulating hormone signaling in granulosa cells. Endocrinology. 2005 146:3362-3367.
465. Palermo R. Differential actions of FSH and LH during folliculogenesis. Reprod Biomed Online. 2007 15:326-337.
466. Pangas SA. Growth factors in ovarian development. Semin Reprod Med. 2007 25:225-234.
467. Peluso JJ. Non-genomic actions of progesterone in the normal and neoplastic mammalian ovary. Semin Reprod Med. 2007 25:198-207.
468. Quirk SM, Cowan RG, Harman RM, Hu CL, Porter DA. Ovarian follicular growth and atresia: the relationship between cell proliferation and survival. J Anim Sci. 2004 82 E-Suppl:E40-E52.
469. Reisinger K, Baal N, McKinnon T, Münstedt K, Zygmunt M. The gonadotropins: tissue-specific angiogenic factors? Mol Cell Endocrinol. 2007 269:65-80.
470. Silva JR, Tharasanit T, Taverne MA, van der Weijden GC, Santos RR, Figueiredo JR, van den Hurk R. The activin-follistatin system and in vitro early follicle development in goats. J Endocrinol. 2006 189:113-125.
471. Silva JR, Figueiredo JR, van den Hurk R. Involvement of growth hormone (GH)and insulin-like growth factor (IGF) system in ovarian folliculogenesis. Theriogenology. 2009 71:1193-1208.
472. Sirotkin AV, Makarevich AV, Kwon HB, Kotwica J, Bulla J, Hetényi L. Do GH, IGF-I and oxytocin interact by regulating the secretory activity of porcine ovarian cells? J Endocrinol. 2001 171:475-480
473. Sirotkin AV, Makarevich AV, Grossmann R, Kotwica J, Schaeffer H-J, Marnet P-G, Kwon H, Sanislo P, Florkovicova I, Petrak J, Rafal J, Pivko J, Hetenyi L. Regulators of ovarian function. In: "Regulation and Evaluation of Ovarian Function and Embryogenesis in Normal and Transgenic Animals in vitro and in vivo"(M.R. Luck ed.). Research Institute of Animal Production, Nitra, Slovakia, 2003, pp. 9-25.
474. Sirotkin AV, Luck M. The ovarian cycle, oogenesis and their regulation. In: Animal Biotechnology (J. Laurincik ed.), Constantine the Philosopher University in Nitra, Prírodovedec, Nitra, Slovak Republic, pp. 10-28 (2008).
475. Skarzynski DJ, Ferreira-Dias G, Okuda K. Regulation of luteal function and corpus luteum regression in cows: hormonal control, immune mechanisms and intercellular communication. Reprod Domest Anim. 2008 43 Suppl 2:57-65.
476. Skinner MK. Regulation of primordial follicle assembly and development. Hum Reprod Update. 200511:461-471.
477. Stadtmauer L, Jones E, Gosden R. The ovarian factor in assisted reproductive technology. In: The Ovary. Second Edition. (Leung PCK and Adash EY eds.) Elsevier-Academic Press, Amsterdam et al. 2004, pp. 461-472.
478. Stouffer RL, Xu F, Duffy DM. Molecular control of ovulation and luteinization in the primate follicle. Front Biosci. 2007 12:297-307.
479. Thomas FH, Vanderhyden BC. Oocyte-granulosa cell interactions during mouse follicular development: regulation of kit ligand expression and its role in oocyte growth. Reprod Biol Endocrinol. 2006 4:19-30.
480. Vegetti W, Alagna F. FSH and folliculogenesis: from physiology to ovarian stimulation. Reprod Biomed Online. 2006 12:684-94.
481. Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction. 2006 131:1-9.
482. Wang C, Roy SK. Expression of bone morphogenetic protein receptor (BMPR) during perinatal ovary development and primordial follicle formation in the hamster: possible regulation by FSH. Endocrinology. 2009 150:1886-1896.
483. Webb R, Campbell BK. Development of the dominant follicle: mechanisms of selection and maintenance of oocyte quality. Soc Reprod Fertil Suppl. 2007 64:141-163
484. Wunsch A, Sonntag B, Simoni M. Polymorphism of the FSH receptor and ovarian response to FSH. Ann Endocrinol (Paris). 2007 68:160-166.
485. Xia Y, Schneyer AL. The biology of activin: recent advances in structure, regulation and function. J Endocrinol. 2009 202:1-12.
486. Ziecik AJ, Blitek A, Kaczmarek MM, Waclawik A, Bogacki M. Inhibition of luteolysis and embryo-uterine interactions during the peri-implantation period in pigs. Soc Reprod Fertil Suppl. 2006 62:147-161.